Pentobarbital will decrease the extent or outcome of lumefantrine by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated. Coadministration with powerful CYP3A4 inducers can result in lowered serum concentrations and lack of antimalarial efficacy pentobarbital will decrease the level or influence of almotriptan by affecting hepatic/intestinal enzyme CYP3A4 metabolism... https://donovanexlao.bloggip.com/31092132/indicators-on-side-effects-of-nembutal-you-should-know